#VisualAbstract: No mortality benefit found for hydroxychloroquine or tocilizumab for the treatment of COVID-19
1. Hydroxychloroquine use in hospitalized and tocilizumab use in ICU lab-positive COVID-19 patients were not been associated with decreased death. ...